The 5 best market analysts: sector expertise and coverage

Marketbeat’s many investor tools include analyst rankings and sentiment trackers. These tools help investors and traders evaluate market sentiment by showing trends and changes, updated reviews and new reports. But which analysts do it best? Because matter? This is important because the best performing analysts will command the most respect from market participants and significantly influence prices.

Marketbeat tracks and ranks analysts based on their performance. The tool analyzes Marketbeat data to find analysts with the best 12-month average ROI based on the report date and stock price twelve months later.

Like all screens, investors should not take the charts at face value. A positive average ROI is one thing if it can be achieved with regular and consistent winnings. The situation is different if the results are driven by unique events and outliers. Take Pablo Zunaic, for example. He is ranked #1 in winning percentage, but he covers cannabis stocks and all the wins are from before the cannabis bubble burst. We all know that the cannabis market has seen a steady decline since then.

#5 Alex Rygiel can consistently produce winners

Alex Rygiel is an associate director of research and senior managing director at B. Riley Securities. He focuses on construction and building materials stocks and is able to consistently produce winning stocks. Its average 12-month ROI is 75% based on forty-four research reports. His deals often don’t produce immediate or significant gains, but they tend to produce double to high double-digit returns in a year almost 100% of the time.

The latest report released by Mr. Rygiel, monitored by Marketbeat, is an update and updated price target for Dycom Industries NYSE:DY. He upgraded the telecom contracting company to Buy from Neutral with a target of $172. The $172 target is up 70% from the previous target and hit a new high, predicting a 20% upside for the stock . The seven analysts tracked by Marketbeat who cover DY stock have it pegged at Buy but see it trading near fair value at $142.

#4 Vernon Bernardino is another winning stock analyst

Vernon Bernardino is a managing director and senior healthcare analyst at HC Wainwright & Co. Bernardino was a healthcare researcher before entering the investment analysis industry. According to Marketbeat, he has over twelve years of industry experience and an average twelve-month ROI of 105%.

Mr. Bernardino consistently produces winners, with only a few losers. He is also a candidate to follow for short-term traders because his 30-day ROI is close to 10%. His most recent call is a reduced price target for Novavax NASDAQ: NVAXsuggesting that a nearly 300% upside is possible.

#3 Mayank Tandon Covers the Fintech sector, 75% win rate.

Mayank Tandon is a senior analyst at Needham covering fintech and payments. He may deliver winners, but his 75% win rate is based on many positions in 2020 and 2021. At least one of them, Grid dynamics NASDAQ: GDYN, is responsible for numerous triple-digit gains due to repeat reviews and ratings. Among his recent reports is a repeated purchase for Alkami technology NASDAQ:ALKT with a price target of $30 or approximately 25% above the current stock.

#2 Geulah Livshits has had good success with the pharmaceutical sector

Geulah Livshits ranks second on this list with a winning percentage of 72.5% based on one hundred and one reports. She is a senior research analyst at Chardon Capital, she works in biotechnology and focuses on gene editing and oncology. Her track record is good, but based on many reports issued regarding COVID-19 and Moderna. Marketbeat.com tracks nine triple-digit gains in the period, mostly gains on Moderna reports and reviews.

Taking this and an unbroken streak of losers into account, its track record is almost 100% bad. The most recently tracked gain/loss is a gain of 122%. Iovance therapy NASDAQ: IOVA. Among the most recently released reports is a revised price target for Iovance. This target is the highest ever recorded and almost 200% higher than current action. Ten analysts rate Iovance Buy and see it advancing 85% consensus.

#1) Yi Chen is the most active analyst who wins

Yi Chen is a managing director at HC Wainwright and a senior healthcare analyst. He is the most active analyst on this list, with one hundred and eighty-five reports. Based on these reports, his track record is 69% and his wins and losses are evenly mixed. His most recent win is a 6% gain on Vaccitech. Among the most recent reports/reviews is a reduced price target for Applied DNA sciences NASDAQ:APDN which sees an increase of over 150% for the penny stock.

Before you consider Dycom Industries, you’ll want to hear this.

MarketBeat tracks Wall Street’s highest-rated and best-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market takes hold… and Dycom Industries wasn’t on the list.

While Dycom Industries currently has a “buy” rating among analysts, top analysts believe these five stocks are better buys.

View the five stocks here